Peptide questions · CagriSema

How long does CagriSema take to work?

Reviewed Evidence: EstablishedPublished by PepVault

CagriSema’s onset is days–2 weeks, its peak effect comes at 68+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: Phase 3 REDEFINE 1 and 2 (NEJM 2025), REDEFINE 5 (Lancet Diabetes Endocrinol 2026) and the REDEFINE 4 headline results (Novo Nordisk, 2026). Under FDA review; not approved.

CagriSema week by week

The library places five of its research notes on CagriSema on the days they cover, from day 1 to day 364 and on: 5 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The CagriSema notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)The 0.25 mg startRandomized trial
Days 29–364 (weeks 5–52)0.5 mg of eachRandomized trial
Days 57–364 (weeks 9–52)1 mg of each, halfway upRandomized trial
Days 85–364 (weeks 13–52)1.7 mg of each, one step from the topRandomized trial
From day 113 on2.4 mg/2.4 mg, the maintenance doseRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track CagriSema in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The CagriSema timeline’s milestones

The library’s timeline for CagriSema marks 7 points from week 1 to week 84, backed by clinical trial data overall.

  • Week 1: Commonly reported: appetite dipping within days, with some nausea after the first shots
  • Week 4: Trial step from 0.25 to 0.5 mg of each component
  • Week 8: Commonly reported: smaller portions and fullness arriving early in a meal
  • Week 16: The trials reach the 2.4 mg/2.4 mg maintenance dose here, after four 4-week steps
  • Week 24: Commonly reported: GI side effects settling once the dose holds steady
  • Week 68: Where REDEFINE 1 and 2 read out
  • Week 84: Where the head-to-head with tirzepatide (REDEFINE 4) read out

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why CagriSema takes that long

CagriSema’s half-life is about 7 days (168 hours), so one dose is about 96.9% cleared after 35 days.

On its schedule (Weekly) the doses overlap, and the level of CagriSema keeps climbing for about 28–35 days before it levels off, so the first 28–35 days run below the level the later weeks hold.

The notes on CagriSema follow the trials’ dose steps, 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

CagriSema against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, CagriSema among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does CagriSema take to work?

CagriSema’s onset is days–2 weeks, its peak effect comes at 68+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does CagriSema reach its peak effect?

By the library’s timeline, CagriSema’s peak effect comes at 68+ weeks, backed by clinical trial data.

How long is CagriSema usually run?

The library’s timeline gives CagriSema’s typical duration as ongoing; its cycle note says: Studied as an ongoing weekly treatment: 68 to 84 weeks in phase 3.

What does the library say about the first days on CagriSema?

Its first note on CagriSema, for days 1–28 (weeks 1–4), is “The 0.25 mg start”, resting on randomized trials.

More on CagriSema

Track it in the app

PepVault for iPhone

Track CagriSema in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo